AMNEAL PHARMS Company Profile
✉ Email this page to a colleague
What is the competitive landscape for AMNEAL PHARMS, and what generic and branded alternatives to AMNEAL PHARMS drugs are available?
AMNEAL PHARMS has two hundred and seventeen approved drugs.
There are five tentative approvals on AMNEAL PHARMS drugs.
Drugs and US Patents for AMNEAL PHARMS
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Amneal Pharms | ENTECAVIR | entecavir | TABLET;ORAL | 206652-001 | Nov 12, 2015 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Amneal Pharms Co | DESIPRAMINE HYDROCHLORIDE | desipramine hydrochloride | TABLET;ORAL | 208105-006 | Mar 17, 2016 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Amneal Pharms Co | EZETIMIBE | ezetimibe | TABLET;ORAL | 208803-001 | Jun 12, 2017 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Amneal Pharms | SUCRALFATE | sucralfate | TABLET;ORAL | 215576-001 | Apr 15, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Paragraph IV (Patent) Challenges for AMNEAL PHARMS drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Injection | 1 mg/mL, 50 mL vials | ➤ Subscribe | 2011-12-16 |
➤ Subscribe | Injection | 100 mg/mL, 2.5 mL vials | ➤ Subscribe | 2007-09-24 |
Similar Applicant Names
Here is a list of applicants with similar names.